19 Stocks and 81 ETFs for diversifying NextDecade (NEXT)
The least correlated asset to NextDecade (NEXT) is ETF TAXT (NORTHERN TRUST TAX-EXEMPT BOND ETF). The correlation is -0.8513.
Stocks that lowly correlated with NEXT
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| KMTS | Kestra Medical Technologies Ltd | $1.44B | Healthcare | Medical Instruments & Supplies | -0.74 |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $674M | Healthcare | Biotechnology | -0.72 |
| EFTY | Etoiles Capital Group Co Ltd - Class A | $287M | Industrials | Consulting Services | -0.70 |
| CTWO | COtwo Advisors Physical European Carbon Allowance Trust | $1.85M | N/A | N/A | -0.69 |
| HBNB | Hotel101 Global Holdings Corp | $1.31B | Real Estate | Real Estate Services | -0.68 |
| BLIV | BeLive Holdings | $27M | Technology | Software - Application | -0.67 |
| NUTR | Nusatrip Inc | $174M | Consumer Cyclical | Travel Services | -0.66 |
| HOND | HCM II Acquisition Corp. Class A Ordinary Shares | $519M | Financial Services | Shell Companies | -0.65 |
| PC | Premium Catering (Holdings) Ltd | $30M | Industrials | Specialty Business Services | -0.64 |
| CMDB | Costamare Bulkers Holdings Ltd | $485M | Industrials | Marine Shipping | -0.63 |
| NPAC | New Providence Acquisition Corp III - Class A | $398M | Financial Services | Shell Companies | -0.63 |
| MBVIU | M3 Brigade Acquisition VI Corp - Units (1 Ord Cls A & 1/3 War) | $77M | Financial Services | Shell Companies | -0.63 |
| TVACW | Texas Ventures Acquisition III Corp - Warrants (23/04/2030) | $153M | N/A | N/A | -0.59 |
| PMI | Picard Medical Inc | $11M | Healthcare | Medical Devices | -0.59 |
| CEPF | Cantor Equity Partners IV Inc - Class A | $597M | Financial Services | Shell Companies | -0.57 |
| YMT | Yimutian Inc | $111M | Technology | Software - Application | -0.57 |
| BUSEP | First Busey Corp | $2.21B | Financial Services | Banks - Regional | -0.57 |
| SKBL | Skyline Builders Group Holding Limited Class A Ordinary Shares | $92M | Industrials | Engineering & Construction | -0.55 |
| NSRX | Nasus Pharma Ltd | $28M | Healthcare | Drug Manufacturers - General | -0.54 |